Image of Canagliflozin and Renal Outcomes in Type 2 Diabetes and Nephropathy

LITERATURE

Canagliflozin and Renal Outcomes in Type 2 Diabetes and Nephropathy


Type 2 diabetes mellitus is the leading cause of kidney failure worldwide, but few effective
long-term treatments are available. In cardiovascular trials of inhibitors of sodium–
glucose cotransporter 2 (SGLT2), exploratory results have suggested that such
drugs may improve renal outcomes in patients with type 2 diabetes.


Availability

REQJ760-01Titan CenterAvailable

Detail Information

Series Title
-
Call Number
-
Publisher : .,
Collation
-
Language
English
ISBN/ISSN
-
Classification
NONE
Content Type
-
Media Type
-
Carrier Type
-
Edition
-
Subject(s)
Specific Detail Info
-
Statement of Responsibility

Other version/related

No other version available


File Attachment



Information


RECORD DETAIL


Back To Previous